We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+6.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$72.5M
AUM Growth
+$956K
Cap. Flow
+$1.31M
Cap. Flow %
1.81%
Top 10 Hldgs %
68.94%
Holding
88
New
10
Increased
5
Reduced
17
Closed
17

Top Buys

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$3.65M
2
XOM icon
ExxonMobil
XOM
+$2.26M
3
VTLE
Vital Energy
VTLE
+$1.5M
4
VRNA
Verona Pharma
VRNA
+$1.21M
5
FANG icon
Diamondback Energy
FANG
+$811K

Top Sells

Rank Stock Value
1
IDYA icon
IDEAYA Biosciences
IDYA
+$2.39M
2
ARCT icon
Arcturus Therapeutics
ARCT
+$1.78M
3
ARWR icon
Arrowhead Research
ARWR
+$989K
4
LNTH icon
Lantheus
LNTH
+$852K
5
CF icon
CF Industries
CF
+$772K

Sector Composition

Rank Sector Weight
1 Healthcare 60.54%
2 Energy 29.19%
3 Technology 7.65%
4 Communication Services 1.77%
5 Industrials 0.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICAD
26
DELISTED
iCAD Inc
ICAD
$431K 0.59%
205,000
– –
U icon
27
Unity
U
$17.5B
$398K 0.55%
12,500
-13,800
-52% -$568K
VIST icon
28
Vista Energy
VIST
$7.15B
$391K 0.54%
41,500
– –
DEN
29
DELISTED
Denbury Inc.
DEN
$345K 0.48%
+4,000
New +$307K
ZETA icon
30
Zeta Global
ZETA
$6.66B
$340K 0.47%
51,500
-21,000
-29% -$130K
XYZ
31
Block Inc
XYZ
$48.2B
$330K 0.46%
+6,000
New +$425K
FUBO icon
32
FuboTV Inc
FUBO
$291M
$284K 0.39%
6,667
-2,500
-27% -$107K
QTEK
33
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$278K 0.38%
138,500
-161,500
-54% -$253K
IMDX
34
Insight Molecular Diagnostics
IMDX
$155M
$241K 0.33%
16,500
– –
EXE
35
Expand Energy Corp
EXE
$21.3B
$236K 0.33%
+2,500
New +$235K
RUM icon
36
RUM Group Inc
RUM
$1.7B
$234K 0.32%
+19,100
New +$209K
CYPH
37
Cypherpunk Technologies Inc
CYPH
$74.3M
$233K 0.32%
26,500
– –
ONCT
38
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$187K 0.26%
10,500
– –
CRDF icon
39
Cardiff Oncology
CRDF
$74.7M
$186K 0.26%
120,600
– –
SURF
40
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$177K 0.24%
170,500
– –
SNOW icon
41
Snowflake
SNOW
$109B
$170K 0.23%
+1,000
New +$166K
AWH
42
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$155K 0.21%
27,808
-15,259
-35% -$164K
DOCN icon
43
DigitalOcean
DOCN
$14.6B
$145K 0.2%
4,000
-6,000
-60% -$252K
FLNA
44
Filana Therapeutics
FLNA
$46.4M
$142K 0.2%
+3,400
New +$91.8K
MRKR icon
45
Marker Therapeutics
MRKR
$20.8M
$131K 0.18%
35,440
– –
NGNE icon
46
Neurogene
NGNE
$723M
$127K 0.18%
9,950
– –
MDNA
47
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$124K 0.17%
149,070
– –
GRTS
48
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$122K 0.17%
47,500
– –
ADAP
49
DELISTED
Adaptimmune Therapeutics
ADAP
$97K 0.13%
90,000
– –
DPRO
50
Draganfly
DPRO
$162M
$95K 0.13%
5,400
– –
1
2
3 4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, ACT Capital Management held 88 positions worth $72.5M, up 1.3% from $71.5M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ACT Capital Management's Q3 2022 filing shows 10 new, 5 increased, 17 reduced and 17 closed positions. Its largest new stake was Axsome Therapeutics: 73,000 shares worth $3.26M. The largest sale was IDEAYA Biosciences, an estimated $2.39M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 67% a quarter earlier, followed by Energy and Technology.

  • ACT Capital Management's largest Q3 2022 buy was Axsome Therapeutics: 73,000 shares worth $3.26M.
  • ACT Capital Management added most to ExxonMobil in Q3 2022, an estimated $2.26M increase.
  • ACT Capital Management's biggest Q3 2022 reduction was Arcturus Therapeutics, cutting an estimated $1.78M.
  • ACT Capital Management fully exited IDEAYA Biosciences in Q3 2022, selling an estimated $2.39M.
  • ACT Capital Management's ten largest holdings make up 69% of its $72.5M portfolio in Q3 2022.
  • ACT Capital Management opened 10 new positions and closed 17 in Q3 2022.
  • ACT Capital Management's portfolio value rose 1.3% quarter-over-quarter to $72.5M.

Based on ACT Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.